pharma · Cancer Anorexia · ARTL
ARTELO BIOSCIENCES
ARTELO BIOSCIENCES, INC.
Artelo Biosciences is a pharma organization headquartered in La Jolla, USA. It trades on NYSE under ticker ARTL. Primary therapeutic focus areas include Cancer Anorexia. NovaPharmaNews links 1 clinical program(s), 0 drug
La Jolla, USA HQ
2017 Founded
16 Employees
Public company Type
ARTL · NYSE Ticker
Company details
- Status
- Public
- HQ
- La Jolla, USA
- Founded
- 2017
- Employees
- 16
- Programs
- 1
- Drugs
- 1
- Patents
- 2
ART27.13-100
Phase 2 · small molecule · Cancer Anorexia
ART27.13-100 for Cancer Anorexia is a Phase 2 program (small_molecule) at ARTELO BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).
Internal code ART27.13-100
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ARTELO BIOSCIENCES, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Cancer Anorexia
- Status
- active
- Trials
- 1